Coagulation Parameters in Post-Covid-19 Condition in Relation to Various Titers of Anti-SARS-CoV-2 IgG in Blood Plasma.
Document Type
Article
Publication Date
12-27-2023
Publication Title
Int J Gen Med
Abstract
BACKGROUND AND OBJECTIVES: Post-COVID-19 condition is thought to affect 10-20% of people at least 3 months after a diagnosis of COVID-19 and two months of symptoms. Post-COVID-19 condition presents itself with many clinical effects with varying degrees of severity ranging from a mild cough to a life-threatening coagulopathy. Our study aimed to identify a relationship between the titers of anti-SARS-CoV-2 IgG and anticoagulation parameters: antithrombin III (ATIII), protein C (PC) and thrombomodulin (TM).
MATERIALS AND METHODS: Blood plasma was collected from healthy donors aged 25-45 who had recovered from COVID-19 3-6 months ago and their titers of anti-SARS-CoV-2 IgG and ATIII, PC, and TM were measured.
RESULTS: We found that concentrations and activities of key anticoagulation parameters (ATIII, PC, and TM) measured in donor plasma during the post-COVID-19 varied in relation to the titers of anti-SARS-CoV-2 IgG.
CONCLUSION: While we identified a dysfunction of anticoagulation parameters in patients with post-COVID-19, we aim to explore the subpopulation antibody IgG fraction directly using in vivo and in vitro experiments with the possibility to contribute to the development of treatment options for post-COVID-19 conditions.
Volume
16
First Page
6127
Last Page
6135
Recommended Citation
Strubchevska K, Rachkovska A, Krenytska D, Karbovskyy V, Kozyk M, Secor B, et al Coagulation parameters in post-covid-19 condition in relation to various titers of Anti-SARS-CoV-2 IgG in blood plasma. Int J Gen Med. 2023 Dec 27;16:6127-6135. doi: 10.2147/IJGM.S425496. PMID: 38156079
DOI
10.2147/IJGM.S425496
ISSN
1178-7074
PubMed ID
38156079